LBA4 Updated Overall Survival (OS) Results from the First-Line (1L) Population in the Phase III MONALEESA-3 Trial of Postmenopausal Patients (PTS) with HR+/HER2− Advanced Breast Cancer (ABC) Treated with Ribociclib (RIB) + Fulvestrant (FUL)
ANNALS OF ONCOLOGY（2022）
Key words
Breast Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined